These parameters are important, as they can help in choosing donors of HSC that harbor more efficient and abundant NKG2A+ KIR− CD57− NK cells to treat acute lymphoblastic leukemia. The gene discussed is KIR3DL1; the disease is acute lymphoblastic leukemia.